Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Disopyramide: Standards, Side effects & Adverse effects

Disopyramide (INN, trade names Norpace and Rythmodan) is an antiarrhythmic medication used in the treatment of ventricular tachycardia. It is a sodium channel blocker and is classified as a Class 1a anti-arrhythmic agent. Disopyramide has a negative inotropic effect on the ventricular myocardium, significantly decreasing the contractility. Disopyramide…

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Disopyramide topic overview

The analysis highlights Standards, Side effects and Adverse effects as prominent areas in the source structure around Disopyramide.

Related topics
34
Source areas
4
Connected nodes
38
Extracted relationships
70
Concept neighborhoods
13
Bridge connections
38

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Adverse effects · 10 topics
Side effects · 10 topics
Overview · 8 topics
Obstructive hypertrophic cardiomyopathy · 6 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol)
Interactive image
AHFS/Drugs.com
Monograph
ATC code
C01BA03 (WHO)
Bioavailability
High
CAS Number
3737-09-5 Y
ChEBI
CHEBI:4657 Y

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Obstructive hypertrophic cardiomyopathy

Side effects

Adverse effects

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Disopyramide connects Entity context

The extracted context around Disopyramide shows recurring relationship patterns in the source. For example, Disopyramide → American Heart Association/American College, Beta-blockers, Cardiology Foundation, Disopyramide's, HCM, Hypertrophic, IB, It, LV, Many, Negative, Pharmacologic, The, United States, When Another extracted example is Disopyramide → Acute, ConstipationBlurred, Dry, GlaucomaAgranulocytosis, Heart, Hypotension, LV, Severe, Urinary. Use these groups to spot repeated connection types before inspecting the individual relationships.

Disopyramide

Top relations

related to Obstructive hypertrophic cardiomyopathy · 15
Disopyramide → American Heart Association/American College, Beta-blockers, Cardiology Foundation, Disopyramide's, HCM, Hypertrophic, IB, It, LV, Many, Negative, Pharmacologic, The, United States, When
has effect · 9
Disopyramide → Acute, ConstipationBlurred, Dry, GlaucomaAgranulocytosis, Heart, Hypotension, LV, Severe, Urinary
related to Mechanism of action · 9
Disopyramide → Anesthetized, AV, Disopyramide's Class, Levites, Phase, PR, QRS, SA, This
Legal status · 3
Disopyramide → BR: Class C1 (Other controlled substances), UK: POM (Prescription only), US: ℞-only
3D model (JSmol) · 1
Disopyramide → Interactive image
AHFS/Drugs.com · 1
Disopyramide → Monograph
ATC code · 1
Disopyramide → C01BA03 (WHO)
Bioavailability · 1
Disopyramide → High
CAS Number · 1
Disopyramide → 3737-09-5 Y
ChEBI · 1
Disopyramide → CHEBI:4657 Y

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

effects patients ventricular used side lv treatment negative effect antiarrhythmic normal inotropic hcm systolic agent quinidine action obstructive also class

Disopyramide relationships Subject–Predicate–Object triples

TTTA extracted 70 structured relationships around Disopyramide. Examples in this analysis include Disopyramide → 3D model (JSmol) → Interactive image and Disopyramide → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
Disopyramide3D model (JSmol)Interactive image1.00infobox
DisopyramideAHFS/Drugs.comMonograph1.00infobox
DisopyramideATC codeC01BA03 (WHO)1.00infobox
DisopyramideBioavailabilityHigh1.00infobox
DisopyramideCAS Number3737-09-5 Y1.00infobox
DisopyramideChEBICHEBI:4657 Y1.00infobox
DisopyramideChEMBLChEMBL517 Y1.00infobox
DisopyramideChemSpider3002 Y1.00infobox
DisopyramideCompTox Dashboard (EPA)DTXSID10455361.00infobox
DisopyramideDrugBankDB00280 Y1.00infobox
DisopyramideECHA InfoCard100.021.0101.00infobox
DisopyramideElimination half-life6.7 hours (range 4 to 10 hours)1.00infobox
DisopyramideExcretionRenal (80%)1.00infobox
DisopyramideFormulaC21H29N3O1.00infobox
DisopyramideIUPHAR/BPS71671.00infobox
DisopyramideKEGGD00303 Y1.00infobox
DisopyramideLegal statusBR: Class C1 (Other controlled substances)1.00infobox
DisopyramideLegal statusUK: POM (Prescription only)1.00infobox
DisopyramideLegal statusUS: ℞-only1.00infobox
DisopyramideMedlinePlusa6824081.00infobox
DisopyramideMelting point94.5 to 95 °C (202.1 to 203.0 °F)1.00infobox
DisopyramideMetabolismHepatic (CYP3A4-mediated)1.00infobox
DisopyramideMolar mass339.483 g·mol−11.00infobox
DisopyramidePregnancy categoryAU: B21.00infobox
DisopyramideProtein binding50% to 65% (concentration-dependent)1.00infobox
DisopyramidePubChem CID31141.00infobox
DisopyramideRoutes of administrationOral, intravenous1.00infobox
DisopyramideTrade namesNorpace1.00infobox
DisopyramideUNIIGFO928U8MQ1.00infobox
Disopyramideis areasonable approach before proceeding to invasive septal reduction0.90text

Related concept clusters Concept neighborhoods

The concept neighborhoods around Disopyramide bring nearby vocabulary together. In this analysis, examples include Patients, Effects and Used. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Disopyramide
    • Patients
    • Effects
    • Used
    • Side
    • Heart
    • Effect
    • Ventricular
    • Myocardium
    • Oral
    • Action
    • Agent
    • Function
  • disopyramide
    • Patients
    • Effects
    • Used
    • Side
    • Heart
    • Effect
    • Ventricular
    • Myocardium
    • Oral
    • Action
    • Agent
    • Function
  • side effects
    • Effects
    • Side
    • Reduction
    • Used
    • Toxic
    • Cardiac
    • Cardiomyopathy
    • Hypertrophic
    • Oral
    • Sodium
    • Action
    • Function
  • adverse effects
    • Also
    • Side
    • Class
    • Intravenous
    • Cardiac
    • Cardiomyopathy
    • Drugs
    • Hypertrophic
    • Oral
    • Quinidine
    • Sodium
    • Effects
  • ventricular tachycardia
    • Effect
    • Negative
    • Treatment
    • Lv
    • Decreasing
    • Myocardium
    • Inotropic
    • Systolic
    • Disopyramide
    • Antiarrhythmic
    • Action
    • Agent
  • left ventricular
    • Effect
    • Negative
    • Treatment
    • Lv
    • Decreasing
    • Myocardium
    • Inotropic
    • Systolic
    • Disopyramide
    • Antiarrhythmic
    • Action
    • Agent
  • obstructive hypertrophic cardiomyopathy
    • Cardiomyopathy
    • Hypertrophic
    • Cardiac
    • Hcm
    • Class
    • Intravenous
    • Drugs
    • Oral
    • Quinidine
    • Sodium
    • Obstructive
    • Heart
  • hypertrophic cardiomyopathy
    • Cardiomyopathy
    • Hypertrophic
    • Cardiac
    • Class
    • Intravenous
    • Drugs
    • Oral
    • Quinidine
    • Sodium
    • Obstructive
    • Hcm
    • Normal

Connections between topic areas Semantic bridges

For Disopyramide, one of the stronger structural bridges in this analysis connects Disopyramide with Side effects. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Disopyramide — Side effects · splits 28 ⟂ 11
Disopyramide — Adverse effects · splits 28 ⟂ 11
Disopyramide — Overview · splits 30 ⟂ 9
Disopyramide — Obstructive hypertrophic cardiomyopathy · splits 32 ⟂ 7

Map overview Semantic statistics

Disopyramide

Nodes39
Edges38
Triples70
Avg. degree1.95
Density0.051282
Components1

Source & methodology

TTTA analyzes the structure around Disopyramide to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Standards, Side effects & Adverse effects, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Disopyramide · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.